Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & working
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global implantable cardioverter defibrillators industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Type trends
2.1.5 End-use trends
Chapter 3 Implantable Cardioverter Defibrillators Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cardiovascular diseases
3.2.1.2 Growing adoption of ICDs due to higher success rates
3.2.1.3 Technological advancement
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with the implantation of ICDs
3.2.2.2 Risk of complications
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By type
3.3.3 By end-use
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Reimbusement scenario
3.6 Future market trends
3.7 Technological landscape
3.8 Pricing analysis
3.9 Indiacation landscape
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Company market share analysis, 2023
4.4 Competitive analysis of major market players, 2023
4.5 Competitive positioning matrix, 2023
4.6 Strategy dashboard, 2023
Chapter 5 Implantable Cardioverter Defibrillators Market Size and Forecast, By Product, 2018-2032 (USD Million)
5.1 Key trends, by product
5.2 Transvenous implantable cardioverter-defibrillators
5.3 Subcutaneous implantable cardioverter defibrillators
Chapter 6 Implantable Cardioverter Defibrillators Market Size and Forecast, By Type, 2018-2032 (USD Million)
6.1 Key trends, by type
6.2 Single-chamber ICDs
6.3 Dual-chamber ICDs
6.4 Biventricular devices
Chapter 7 Implantable Cardioverter Defibrillators Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users
Chapter 8 Implantable Cardioverter Defibrillators Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Medtronic plc
9.3 BIOTRONIK SE & Co. KG
9.4 Boston Scientific Corporation
9.5 MicroPort Scientific Corporation
9.6 LivaNova plc
9.7 FUKUDA DENSHI CO. Ltd.
9.8 IMRICOR MEDICAL SYSTEMS
9.9 Koninklijke Philips N.V.
9.10 Nohen Kohden Corporation
9.11 CU Medical Germany GmbH
9.12 MEDIANA Co., Ltd.
